|
Applications are invited for a temporary post of a Research Scientist within UCD School of Biomolecular and Biomedical Science.
Acute myeloid leukaemia (AML) is an aggressive blood cancer that originates from primitive stem cells in the bone marrow. Translocations involving the mixed lineage leukaemia (MLL) gene are associated with particularly aggressive subtypes of AML (MLL-r). MLL harnesses the gene regulatory mechanisms of the cell to augment transcriptional programmes and potentiate a leukemic stem cell (LSC) phenotype characterised by unlimited self-renewal capacity and chemoresistance.
Our lab is focused on gaining a greater understanding of the dynamic and intricate gene regulatory mechanisms that contribute to leukemogenesis with the aim of identifying novel candidates for targeted therapies. This work will focus on deciphering the importance of mRNA transcript stability during the process of leukemogenesis. We will use multiple genome-wide sequencing techniques, knock-out/knock-in mouse models and in vitro, in vivo and PDX models of leukaemia.
This is a research focused role where you will join a new and growing research team and contribute heavily to the research output of the group. The primary purpose of the role is to further develop your research skills and competencies, laboratory organisation, provide mentorship to graduate students and engage with outreach activities.
Fixed Salary: €38,000 Per Annum
Closing date: 12:00 noon (local Irish time) on 24 November 2026.
Applications must be submitted by the closing date and time specified. Any applications which are still in progress at the closing time of 12:00 noon (Local Irish Time) on the specified closing date will be cancelled automatically by the system. UCD are unable to accept late applications.
UCD do not require assistance from Recruitment Agencies. Any CVs submitted by Recruitment Agencies will be returned.
UCDITS
|